Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer
Tex Heart Inst J. 2024 Apr 9;51(1):e238375. doi: 10.14503/THIJ-23-8375.ABSTRACTPatients with type 2 diabetes face an elevated risk of cardiovascular disease. This review centers on sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of drugs that, according to a growing body of evidence, may have major potential for managing cardiovascular disease in patients with type 2 diabetes. This review presents findings from multiple clinical trials suggesting that SGLT2 inhibitors can not only serve as preventive therapeutic agents but also play a role in the active management of heart failure. The discussion includes the me...
Source: Texas Heart Institute Journal - April 9, 2024 Category: Cardiology Authors: Allan Zhang Ramsey Kalil Alexander Marzec Stephanie A Coulter Salim Virani Kershaw V Patel Matthew W Segar Source Type: research
Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer
Tex Heart Inst J. 2024 Apr 9;51(1):e238375. doi: 10.14503/THIJ-23-8375.ABSTRACTPatients with type 2 diabetes face an elevated risk of cardiovascular disease. This review centers on sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of drugs that, according to a growing body of evidence, may have major potential for managing cardiovascular disease in patients with type 2 diabetes. This review presents findings from multiple clinical trials suggesting that SGLT2 inhibitors can not only serve as preventive therapeutic agents but also play a role in the active management of heart failure. The discussion includes the me...
Source: Texas Heart Institute Journal - April 9, 2024 Category: Cardiology Authors: Allan Zhang Ramsey Kalil Alexander Marzec Stephanie A Coulter Salim Virani Kershaw V Patel Matthew W Segar Source Type: research
Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer
Tex Heart Inst J. 2024 Apr 9;51(1):e238375. doi: 10.14503/THIJ-23-8375.ABSTRACTPatients with type 2 diabetes face an elevated risk of cardiovascular disease. This review centers on sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of drugs that, according to a growing body of evidence, may have major potential for managing cardiovascular disease in patients with type 2 diabetes. This review presents findings from multiple clinical trials suggesting that SGLT2 inhibitors can not only serve as preventive therapeutic agents but also play a role in the active management of heart failure. The discussion includes the me...
Source: Texas Heart Institute Journal - April 9, 2024 Category: Cardiology Authors: Allan Zhang Ramsey Kalil Alexander Marzec Stephanie A Coulter Salim Virani Kershaw V Patel Matthew W Segar Source Type: research
Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer
Tex Heart Inst J. 2024 Apr 9;51(1):e238375. doi: 10.14503/THIJ-23-8375.ABSTRACTPatients with type 2 diabetes face an elevated risk of cardiovascular disease. This review centers on sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of drugs that, according to a growing body of evidence, may have major potential for managing cardiovascular disease in patients with type 2 diabetes. This review presents findings from multiple clinical trials suggesting that SGLT2 inhibitors can not only serve as preventive therapeutic agents but also play a role in the active management of heart failure. The discussion includes the me...
Source: Texas Heart Institute Journal - April 9, 2024 Category: Cardiology Authors: Allan Zhang Ramsey Kalil Alexander Marzec Stephanie A Coulter Salim Virani Kershaw V Patel Matthew W Segar Source Type: research
Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer
Tex Heart Inst J. 2024 Apr 9;51(1):e238375. doi: 10.14503/THIJ-23-8375.ABSTRACTPatients with type 2 diabetes face an elevated risk of cardiovascular disease. This review centers on sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of drugs that, according to a growing body of evidence, may have major potential for managing cardiovascular disease in patients with type 2 diabetes. This review presents findings from multiple clinical trials suggesting that SGLT2 inhibitors can not only serve as preventive therapeutic agents but also play a role in the active management of heart failure. The discussion includes the me...
Source: Texas Heart Institute Journal - April 9, 2024 Category: Cardiology Authors: Allan Zhang Ramsey Kalil Alexander Marzec Stephanie A Coulter Salim Virani Kershaw V Patel Matthew W Segar Source Type: research
Transient 2:1 Atrioventricular Block with Peri-Conduction System Pacing After Leadless Pacemaker Implantation
This report discusses a case of transient 2:1 atrioventricular block with conduction system pacing 4 hours after leadless right ventricular pacemaker implantation in a 19-year-old patient with a history of cardioinhibitory syncope and asystole cardiac arrest but without preexisting atrioventricular block. The atrioventricular block was resolved spontaneously. Pacing morphology was suggestive of right bundle branch pacing. Neither 2:1 atrioventricular block nor conduction system pacing has previously been a reported outcome of right ventricular leadless pacemaker implantation. The report demonstrates that conduction system ...
Source: Texas Heart Institute Journal - April 2, 2024 Category: Cardiology Authors: Salim N Najjar Michael A Bruno Wilson W Lam Source Type: research
Transient 2:1 Atrioventricular Block with Peri-Conduction System Pacing After Leadless Pacemaker Implantation
This report discusses a case of transient 2:1 atrioventricular block with conduction system pacing 4 hours after leadless right ventricular pacemaker implantation in a 19-year-old patient with a history of cardioinhibitory syncope and asystole cardiac arrest but without preexisting atrioventricular block. The atrioventricular block was resolved spontaneously. Pacing morphology was suggestive of right bundle branch pacing. Neither 2:1 atrioventricular block nor conduction system pacing has previously been a reported outcome of right ventricular leadless pacemaker implantation. The report demonstrates that conduction system ...
Source: Texas Heart Institute Journal - April 2, 2024 Category: Cardiology Authors: Salim N Najjar Michael A Bruno Wilson W Lam Source Type: research
Transient 2:1 Atrioventricular Block with Peri-Conduction System Pacing After Leadless Pacemaker Implantation
This report discusses a case of transient 2:1 atrioventricular block with conduction system pacing 4 hours after leadless right ventricular pacemaker implantation in a 19-year-old patient with a history of cardioinhibitory syncope and asystole cardiac arrest but without preexisting atrioventricular block. The atrioventricular block was resolved spontaneously. Pacing morphology was suggestive of right bundle branch pacing. Neither 2:1 atrioventricular block nor conduction system pacing has previously been a reported outcome of right ventricular leadless pacemaker implantation. The report demonstrates that conduction system ...
Source: Texas Heart Institute Journal - April 2, 2024 Category: Cardiology Authors: Salim N Najjar Michael A Bruno Wilson W Lam Source Type: research
Transient 2:1 Atrioventricular Block with Peri-Conduction System Pacing After Leadless Pacemaker Implantation
This report discusses a case of transient 2:1 atrioventricular block with conduction system pacing 4 hours after leadless right ventricular pacemaker implantation in a 19-year-old patient with a history of cardioinhibitory syncope and asystole cardiac arrest but without preexisting atrioventricular block. The atrioventricular block was resolved spontaneously. Pacing morphology was suggestive of right bundle branch pacing. Neither 2:1 atrioventricular block nor conduction system pacing has previously been a reported outcome of right ventricular leadless pacemaker implantation. The report demonstrates that conduction system ...
Source: Texas Heart Institute Journal - April 2, 2024 Category: Cardiology Authors: Salim N Najjar Michael A Bruno Wilson W Lam Source Type: research
Transient 2:1 Atrioventricular Block with Peri-Conduction System Pacing After Leadless Pacemaker Implantation
This report discusses a case of transient 2:1 atrioventricular block with conduction system pacing 4 hours after leadless right ventricular pacemaker implantation in a 19-year-old patient with a history of cardioinhibitory syncope and asystole cardiac arrest but without preexisting atrioventricular block. The atrioventricular block was resolved spontaneously. Pacing morphology was suggestive of right bundle branch pacing. Neither 2:1 atrioventricular block nor conduction system pacing has previously been a reported outcome of right ventricular leadless pacemaker implantation. The report demonstrates that conduction system ...
Source: Texas Heart Institute Journal - April 2, 2024 Category: Cardiology Authors: Salim N Najjar Michael A Bruno Wilson W Lam Source Type: research
Distal Extent of Resection in Type A Dissection: Keeping It Simple
Tex Heart Inst J. 2024 Mar 21;51(1):e238371. doi: 10.14503/THIJ-23-8371.NO ABSTRACTPMID:38509048 | DOI:10.14503/THIJ-23-8371 (Source: Texas Heart Institute Journal)
Source: Texas Heart Institute Journal - March 21, 2024 Category: Cardiology Authors: Marc R Moon Puja Kachroo Source Type: research
Distal Extent of Resection in Type A Dissection: Keeping It Simple
Tex Heart Inst J. 2024 Mar 21;51(1):e238371. doi: 10.14503/THIJ-23-8371.NO ABSTRACTPMID:38509048 | DOI:10.14503/THIJ-23-8371 (Source: Texas Heart Institute Journal)
Source: Texas Heart Institute Journal - March 21, 2024 Category: Cardiology Authors: Marc R Moon Puja Kachroo Source Type: research
Distal Extent of Resection in Type A Dissection: Keeping It Simple
Tex Heart Inst J. 2024 Mar 21;51(1):e238371. doi: 10.14503/THIJ-23-8371.NO ABSTRACTPMID:38509048 | DOI:10.14503/THIJ-23-8371 (Source: Texas Heart Institute Journal)
Source: Texas Heart Institute Journal - March 21, 2024 Category: Cardiology Authors: Marc R Moon Puja Kachroo Source Type: research
Distal Extent of Resection in Type A Dissection: Keeping It Simple
Tex Heart Inst J. 2024 Mar 21;51(1):e238371. doi: 10.14503/THIJ-23-8371.NO ABSTRACTPMID:38509048 | DOI:10.14503/THIJ-23-8371 (Source: Texas Heart Institute Journal)
Source: Texas Heart Institute Journal - March 21, 2024 Category: Cardiology Authors: Marc R Moon Puja Kachroo Source Type: research
Distal Extent of Resection in Type A Dissection: Keeping It Simple
Tex Heart Inst J. 2024 Mar 21;51(1):e238371. doi: 10.14503/THIJ-23-8371.NO ABSTRACTPMID:38509048 | DOI:10.14503/THIJ-23-8371 (Source: Texas Heart Institute Journal)
Source: Texas Heart Institute Journal - March 21, 2024 Category: Cardiology Authors: Marc R Moon Puja Kachroo Source Type: research
